Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Results

24th Jun 2011 07:00

RNS Number : 0142J
Sorbic International PLC
24 June 2011
 



 

Press Release

 24 June 2011

 

Sorbic International Plc

 

("Sorbic" or the "Group" or the "Company")

 

Interim Results

 

Sorbic International plc, (AIM:SORB), the third largest sorbates producer in China, today announces its unaudited Interim Results for the six months period ended 31 March 2011.

 

Summary

 

·;

Revenue for the period was up 27.1% at £6.9 million (H1 2010: £5.4 million)

·;

Gross profit margin for the period of 10.7% (H1 2010: 21.8%) due to increases in raw material costs

·;

EBITDA for the period of £0.35 million (H1 2010: £0.66 million)

·;

Net profit after tax and exchange differences of £0.03 million (H1 2010: £0.84 million)

·;

Cash reserves at the end of the period were £7.27 million (H1 2010: £6.03 million)

·;

Net assets of £14.99 million as at 31 March 2011 (H1 2010: £13.85 million)

·;

Ongoing negotiations with customers to increase selling prices where possible, outside the long-term contracts which are in place

 

Since period end

 

·;

RMB16 million (£1.52 million) injected into China subsidiary for Inner Mongolia construction

·;

Construction in Inner Mongolia on track for completion by end of 2011

·;

Selling prices are starting to improve slightly with costs stabilising in the last two months, thereby supporting a possible recovery in margins

 

John McLean, Non-Executive Chairman, commented: "Sorbic has made strong progress in terms of its output, although profits have been constrained by the rising costs of raw materials, and it is expected that this will further impact the Group going forward. However, the move to Inner Mongolia will improve control of costs and the Board is confident of the ongoing demand for the Group's products.

 

"Although the Group has been impacted by rising commodity prices which have affected margins, these are now improving and the Board remains focused on doubling our capacity to support an expanding domestic food preservative market. The longer term prospects for the Group remain strong, given the investment that has been made in Sorbic's infrastructure and market positioning."

 

- Ends-

For further information:

Sorbic International Plc

John McLean, Non-Executive Chairman

Tel: +44 (0) 7768 031 454

www.sorbicinternational.com

 

FinnCap

Geoff Nash / Ed Frisby (Corporate Finance)

Tel: +44 (0) 20 7600 1658

Tom Jenkins / Simon Starr (Broking)

 

Media enquiries:

Abchurch Communications

Henry Harrison-Topham / Joanne Shears

Tel: +44 (0) 20 7398 7709

[email protected]

www.abchurch-group.com

 

Notes to Editors:

Sorbic International's principal activity is the production and sale of the food preservatives Sorbic Acid and Potassium Sorbate from its base in Linyi City, Shandong Province, People's Republic of China. Approximately half of Sorbic International's production is sold to overseas markets, across 46 countries and half into the Chinese domestic market.

 

Sorbic Acid is a naturally occurring organic compound that is used in all kinds of foods for its anti-decomposition and anti-fungus function and also in grains, medicines, cosmetics, toothpaste, tobacco, animal feed, latex, paper-manufacturing and pesticides. Potassium Sorbate is used to inhibit moulds and yeasts in many foods, such as cheese, wine, yogurt, dried meat, baked goods, cosmetics and pharmaceuticals.

 

Sorbic International operates through its wholly owned subsidiary Linyi Van Science and Technique Co., Ltd ("LVST").

 

Chairman's Statement

 

 

Operational overview

 

During the first half of the year, the plant in Linyi produced an output of 3,185 tonnes of sorbates compared to 2,637 tonnes in the same period last year. The steady production levels through the first six months of the financial year have resulted in revenue growth of 27.1% to £6.9 million (H1 2010: £5.4 million).

 

However against a backdrop of surging oil prices, the costs for crotonaldehyde, a key component in the production of sorbates, increased significantly between October 2010 and March 2011 and this has impacted the Group's profitability. As a result of these increased raw material costs, the gross profit margin for the period decreased to 10.7% (H1 2010: 21.8%). The Board is pleased to note that these raw material costs have stabilised over the last two months.

 

The Group has been negotiating with customers to increase selling prices in order to increase profitability. However, as more than 30% of the Group's sales are locked-in under long-term contracts, the pace of the price increase will lag behind the escalating raw material prices. Selling prices are starting to increase and the Company expects the firming of prices to continue during the second half of the year when next year's contracts are being negotiated.

 

The Group is actively managing its administrative cost base and has carried out regular reviews to reduce overheads where possible to conserve cash resources. These measures have produced positive results over the past six months.

 

Sorbic's balance sheet remains strong with over £7.2 million of cash to support existing operations.

 

Capital raised

The Company raised £1.6 million through a combination of debt and equity in February 2011 to supplement the capital expansion in Inner Mongolia. RMB16 million (£1.52 million) has been injected into the Group's China subsidiary where construction has resumed in early April 2011 and equipment ordered for delivery in July 2011.

 

Under IFRS 16 the Company is required to capitalise the Convertible Loan Notes interest incurred until the completion of the facilities. This interest will be amortised on a straight-line basis over ten years and is subject to review by the Board annually. The interest capitalised for the period amounted to £76,871.

 

New production facility

The Group's new facility in Ulanqab City, Inner Mongoila, is currently under construction and it is anticipated that this will double the existing production capacity once fully operational. Gross profit margins are also expected to increase at the new facility and the Group will benefit from lower operational costs at the Chahar Industrial Park. The new site has the capacity for further expansion of an additional six lines at a later stage in the Company's development.

 

The anticipated costs of the new production facility continued to be within planned budgets.

 

Outlook

China's economic outlook remains favorable with real GDP growth projected at 9.3% in 2011 and 8.7% in 2012. While consumption growth slowed in early 2011, overall domestic demand has remained strong. However, as much of the impact of the higher oil and industrial commodity prices is yet to be fully realised and inflation expectations are high, the Group is expected to incur an overall small loss for the current financial year.

 

The move to Inner Mongolia will place Sorbic in a strong position in the market, particularly related to competitors who are located in higher cost environments.The Board remains optimistic about the longer term prospects for the Group and firmly believes that Sorbic has the right internal infrastructure and skills in place to continue its focus on doubling our capacity to support an expanding food preservative market.

 

 

John McLean

Non-Executive Chairman

23 June 2011

Unaudited condensed consolidated statement of comprehensive income

For the six month period ended 31 March 2011

 

 

Notes

Six months

ended

31 March

2011

Six months

ended

31 March

2010

Year

ended

30 September

2010

Unaudited

Unaudited

Audited

£

£

£

Revenue

6,890,229

5,420,919

12,051,877

Cost of sales

(6,153,415)

(4,238,992)

(9,824,465)

Gross profit

736,814

1,181,927

2,227,412

Distribution and selling expenses

(111,948)

(64,037)

(146,898)

Administrative expenses

(542,130)

(706,088)

(1,302,958)

Operating profit

82,736

411,802

777,556

Finance income

9,375

14,973

26,415

Finance costs

(85,358)

(92,160)

(201,534)

Profit before taxation

6,753

334,615

602,437

Income tax expense

4

(63,899)

(114,720)

(253,751)

(Loss)/ Profit for the period

(57,146)

219,895

348,686

Other comprehensive income

- Exchange differences on translating foreign operations

86,406

618,499

464,335

Total comprehensive income, net of tax

29,260

838,394

813,021

(Loss)/Profit attributable to equity holders of the parent

(57,146)

219,895

348,686

Total comprehensive income for the year attributable to equity holders of the parent

29,260

838,394

813,021

Earnings per share (pence):

Basic

-

0.66

1.04

Diluted

-

0.66

0.90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited consolidated statement of financial position

As at 31 March 2011

 

 

 

 

 

Notes

As at

31 March

2011

As at

31 March

2010

As at

30 September

2010

Unaudited

Unaudited

Audited

£

£

£

Assets

Non-current assets

Property, plant and equipment

8,524,108

8,173,867

8,612,303

Land use rights

3,797,943

2,332,839

3,790,099

12,322,051

10,506,706

12,402,402

Current assets

Inventories

427,811

372,884

361,895

Trade receivables

1,406,729

1,134,750

1,331,775

Prepayments, deposits and other receivables

219,520

251,896

247,102

Amount due from related company- Hermes Financial

5

-

301,625

301,625

Amount due from director

5,821,046

5,644,341

5,775,770

Cash and cash equivalents

7,268,719

6,028,247

5,664,954

15,143,825

13,733,743

13,683,121

Total assets

27,465,876

24,240,449

26,085,523

 

 

 

Equity and liabilities

 

 

Current liabilities

 

 

Trade payables

 

247,239

117,851

190,077

Advanced payments

 

150,897

-

139,527

Accruals and other payables

 

316,088

674,845

580,402

Amount due to directors

 

8,006,382

5,927,542

7,937,541

Borrowings

 

1,424,771

2,901,330

1,412,520

Current tax liabilities

 

30,978

78,394

100,508

Amount due to related company- Hermes Capital

5

-

177,274

93,742

Amount due to related company- Albany Capital

 

352,812

508,942

341,070

 

 

10,529,167

10,386,178

10,795,387

Non-current liability

 

Convertible loan notes

 

1,937,675

-

1,408,969

Total liabilities

 

12,466,842

10,386,178

12,204,356

Capital and reserves

 

 

 

Share capital

 

2,313,810

2,003,310

2,003,310

Share premium

 

21,841,985

21,079,289

21,079,289

Capital reserve

 

2,630,631

2,678,441

2,608,012

Surplus reserve

 

468,944

477,467

464,912

Retained earnings

 

7,293,852

7,222,207

7,350,998

Share based payment reserve

 

30,000

30,000

30,000

Reverse acquisition reserve

 

(20,911,925)

(20,911,925)

(20,911,925)

Foreign currency translation reserve

 

1,715,410

1,726,835

1,655,655

Hedging reserve

 

(451,353)

(451,353)

(451,353)

Convertible loan notes - Equity

 

67,680

-

52,269

Total equity

 

14,999,034

13,854,271

13,881,167

Total equity and liabilities

 

27,465,876

24,240,449

26,085,523

 

 

Unaudited condensed statement of cash flows

For the six month period ended31 March 2010

 

Six months

ended

31 March

2011

Six months

ended

31 March

2010

Year

ended

30 September

2010

Unaudited

Unaudited

Audited

£

£

£

Cash flows from operating activities

Profit for the period

6,753

334,615

602,437

Adjustments for:

Amortisation of prepaid land lease payments

25,019

24,184

49,697

Depreciation

241,725

228,863

472,418

Interest income

(9,375)

(14,973)

(26,415)

Interest expense

85,358

92,160

202,973

Gain/ (loss) on disposal of fixed assets

-

20,961

21,537

Operating profit before working capital changes:

349,480

685,810

1,322,647

Changes in working capital

(Increase)/ decrease in Inventories

(62,777)

(27,176)

(25,278)

(Increase)/ decrease in trade and other receivables

(70,907)

(86,942)

(348,089)

Increase in trade and other payables

137,768

412,282

2,645,472

Cash generated from operating activities

353,564

983,974

3,594,752

Interest (paid)/ received

(85,358)

(92,160)

(202,973)

Income tax paid

(136,290)

(147,763)

(251,598)

Net cash generated from operating activities

131,916

744,051

3,140,181

Cash flows from investing activities

Acquisition of property, plant and equipment

(78,909)

(159,475)

(1,055,463)

Interest received

9,374

14,973

26,415

Additions to prepaid lease payment

-

-

(1,545,709)

Net cash used in investing activities

(69,535)

(144,502)

(2,574,757)

Cash flows from financing activities

Proceeds from issuance of new share

960,399

-

-

Shareholders loan raised

-

193,422

-

Repayment of loan from financial institution

-

-

(1,412,520)

Proceeds from issuance of convertible loans notes

544,117

-

1,447,699

Payment of deemed dividend tax

-

(1,169,194)

(1,138,450)

Net cash from/(used in) financing activities

1,504,516

(975,772)

(1,103,271)

Net decrease in cash and cash equivalents

1,566,897

(376,223)

(537,847)

Cash and cash equivalents at the beginning of the period

5,664,954

5,992,035

5,992,035

Exchange gain on cash and cash equivalent

36,868

412,435

210,766

 

Cash and cash equivalents at the end of the period

7,268,719

6,028,247

5,664,954

Unaudited condensed consolidated statement of changes in equity

For the six month period ended31 March2011

 

Share capital

Share premium

Capital reserve

Surplus reserve

Retained earning

Share based payment reserve

Foreign

currency

translation

reserve

Reverse

acquisition

reserve

Hedging Reserve

Convertible loan notes - equity

Total equity attributable to

equity holders

of the parent

£

£

£

£

£

£

£

£

£

£

£

Balance at 1 October 2009

2,003,310

21,079,289

2,519,393

449,114

7,002,312

30,000

1,295,737

(20,911,925)

(451,353)

-

13,015,877

Profit for the period

-

-

-

-

219,895

-

-

-

-

-

219,895

 

Other comprehensive income:

Exchange differences on translation of foreign operations

-

-

159,048

28,353

-

-

431,098

-

-

-

618,499

Total comprehensive income for the period

-

-

159,048

28,353

219,895

-

431,098

-

-

-

838,394

Balance at 31 March 2010

2,003,310

21,079,289

2,678,441

477,467

7,222,207

30,000

1,726,835

(20,911,925)

(451,353)

-

13,854,271

 

Balance at 1 October 2010

2,003,310

21,079,289

2,608,012

464,912

7,350,998

30,000

1,655,655

(20,911,925)

(451,353)

52,269

13,881,167

Issue of ordinary share

310,500

724,500

-

-

-

-

-

-

-

-

1,035,000

 

Share issue costs

-

38,196

-

-

-

-

-

-

-

-

(187,400)

 

Convertible loan notes - equity

-

-

-

-

-

-

-

-

-

15,411

15,411

 

Profit for the period

-

-

-

-

(57,146)

-

-

-

-

-

(57,146)

 

 

Other comprehensive income:

 

Exchange differences on translation of foreign operations

-

-

22,619

4,032

-

-

59,755

-

-

-

86,406

Total comprehensive income for the period

-

-

22,619

4,032

(57,146)

-

59,755

-

-

-

29,260

 

Balance at 31 March 2011

2,313,810

21,841,985

2,630,631

468,944

7,293,852

30,000

1,715,410

(20,911,925)

(451,353)

67,680

14,999,034

Basis of Presentation and Summary of Significant Accounting Policies

 

 

1.

General information

 

The Company was established to seek to acquire a controlling interest in a company located in Europe, North America or Asia. Following the change of name from Ninety plc to Sorbic International plc and the completion of the acquisition of Honour Field International Limited ("HF") and its subsidiary ("Honour Field Group") on 29 September 2008, the Group's principal activities comprise the production and sale of food preservatives, namely Sorbic Acid and Potassium Sorbate. The Group's main operations are in the People's Republic of China.

 

Sorbic International, a public limited company, is the Group's ultimate parent company. It is incorporated and domiciled in the United Kingdom. The address of Sorbic International's registered office is 3rd Floor, 49 Whitehall, London SW1A 2BX. Sorbic International's shares are traded on the AIM market of the London Stock Exchange.

 

2.

Basis of preparation

 

The financial information for the six months ended 31 March 2010 and 31 March 2011 set out in this interim financial information is unaudited and does not constitute statutory financial statements. The financial information for the year ended 30 September 2010 set out in this interim financial information does not comprise the Group's statutory financial statements as defined in Section 435 Companies Act 2006 but has been extracted from those financial statements.

 

The directors approved the interim financial information for the six months ended 31 March 2011 on 23 June 2011.

 

Copies of this interim financial information will be available on the Company's website: www.sorbicinternational.com

 

The interim financial information has been prepared in accordance with IAS 34 "Interim financial reporting" as adopted by the European Union. The standards have been applied consistently (except as otherwise stated).

 

The statutory financial statements for the year ended 30 September 2010, which have been filed at Companies House, were prepared under IFRS and IFRIC interpretations as adopted by the European Union and with those parts of the Companies Act 2006 applicable to companies preparing their financial statements under IFRS. The auditors reported on those financial statements; their Audit Report was unqualified and did not contain a statement under either Section 498(2) or 498(3) of the Companies Act 2006.

 

The Group has adopted the following new interpretations, revisions and amendments to IFRS issued by the International Accounting Standards Board, which are relevant to and effective for the Group's financial statement for the financial year beginning 1 October 2010:

 

- IFRS 3 Business Combinations (Revised 2008)

- IAS 27 Consolidated and Separate Financial Statements (Revised 2008)

- Improvements to IFRS 2009

 

a. IFRS 3 - Business Combinations (Revised 2008)

 

The revised standard on business combination (IFRS 3) introduced major changes to the accounting requirement for business combinations. It retains the major features of the purchase method of accounting, now referred to as the acquisition method. The most significant changes in IFRS 3 that will have an impact on the Group's acquisition in future are as follows:

 

·; acquisition-related costs of the combination are recorded as an expense in the income statement. Previously, these costs would have been accounted for as part of the cost of the acquisition

 

·; any contingent consideration, is measured at fair value at the acquisition date. If the contingent consideration arrangement gives rise to a financial liability, any subsequent changes are generally recognised in profit or loss. Previously, contingent consideration was recognised only once its payment was probable and changes were recognised as an adjustment to goodwill

·; the measurement of assets acquired and liabilities assumed at their acquisition-date fair values is retained. However, IFRS 3R includes certain exceptions and provides specific measurement rules.

 

For the period ended 31 March 2011, the adoption of IFRS 3R has no effect on the Group's financial statements, as there was no acquisition during the period.

 

b. Improvements to IFRS (2009 and 2010)

 

The improvement to IFRS 2009 & 2010 made several minor amendments to IFRSs. The adoption of these did not have any material effect in these interim consolidated financial statements.

 

 

3.

Segmental reporting

 

The Group has adopted IFRS 8, Operating Segments for the March 2011 interim reporting. IFRS 8 requires that segments represent the level at which financial information is reported to the Board of directors ("The Board") of the Group, being the chief operating decision maker as defined in IFRS 8. The Board consists of the Chairman, the President, the Chief Executive Officer, the Chief Financial Officer and the independent director. The Board determines the operating segments based on reports reviewed and used by the Board for strategic decision making and resource allocation.

 

Segment information is presented in respect of the Group's geographical and operating segments.

 

The Group's operating segments are as follows:

(i) Sorbic acid

(ii) Potassium sorbate

 

There were no inter-segment sales and transfers during the six month period ended 31 March 2011.

 

 

Six months

ended

Six months

ended

Year

ended

31-Mar-11

31-Mar-10

30-Sep-10

£

£

£

PRC

3,240,264

2,807,412

5,505,996

United States

1,857,651

1,057,397

2,858,057

Russia

618,784

355,485

912,978

Netherlands

553,563

549,382

1,265,591

Other

619,967

651,243

1,509,255

Consolidated

6,890,229

5,420,919

12,051,877

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Segments - Six months ended 31 March 2011

 

Sorbic Acid

Potassium Sorbate

Unallocated

Consolidated

£

£

£

£

Revenue

3,296,001

3,594,228

-

6,890,229

Gross profit

244,395

492,419

-

736,814

Profit before taxation

-

-

6,753

6,753

Taxation

-

-

(63,899)

(63,899)

Net profit after tax

-

-

(57,146)

(517,146))

Segment assets

415,350

339,113

27,013,038

27,767,501

Segment liabilities

-

-

(12,881,265)

(12,881,265)

Finance income

-

-

9,375

9,375

Finance costs

-

-

(85,358)

(85,358)

Depreciation and amortisation

131,885

134,859

-

266,744

Capital expenditure

-

-

2,038

2,038

 

Operating Segments - Six months ended 31 March 2010

 

Sorbic Acid

Potassium Sorbate

Unallocated

Consolidated

£

£

£

£

Revenue

2,574,463

2,846,456

-

5,420,919

Gross profit

532,586

649,341

-

1,181,927

Profit before taxation

-

-

334,615

334,615

Taxation

-

-

(114,720)

(114,720)

Net profit after tax

-

-

219,895

219,895

Segment assets

495,206

395,275

23,349,968

24,240,449

Segment liabilities

-

-

(10,386,178)

(10,386,178)

Finance income

-

-

14,973

14,973

Finance costs

-

-

(92,160)

(92,160)

Depreciation and amortisation

125,185

127,862

-

253,047

Capital expenditure

-

-

54,429

54,429

 

Operating Segments - Year ended 30 September 2011

 

Sorbic Acid

Potassium Sorbate

Unallocated

Consolidated

£

£

£

£

Revenue

5,735,928

6,315,949

-

12,051,877

Gross profit

945,765

1,281,647

-

2,227,412

Profit before taxation

-

-

602,437

602,437

Taxation

-

-

(253,751)

(253,751)

Net profit after tax

-

-

348,686

348,686

Segment assets

446,982

359,925

25,278,616

26,085,523

Segment liabilities

-

-

(12,204,356)

(12,204,356)

Finance income

-

-

26,415

26,415

Finance costs

-

-

(201,534)

(201,534)

Depreciation and amortisation

243,803

228,615

49,697

522,115

Capital expenditure

-

-

1,207,111

1,207,111

 

4.

Taxation

 

The taxation charge for the six months ended 31 March 2011 has been based on the estimated effective rate of 25% from October 2010 to March 2011.

 

The Group's subsidiary, Linyi Van Science and Technique Company Limited ("LVST") has had the benefit of a tax holiday from 2004 in which it is entitled to be exempted from the Enterprise Income Tax ("EIT") for tax years starting from the first profit making year followed by a 50% tax relief for the next three years. The tax holiday granted expired from 1 January 2010 onwards.

 

 

5.

Amount due from/ to related companies - Hermes Financial and Hermes Capital

 

The balance due from Hermes Financial of £301,625 being the remaining amount that Hermes Financial owed in relation to the reverse acquisition exercise was netted-off against the amount due to Hermes Capital with a resultant nil balance.

 

In respect to the work that Hermes Capital carried out for Sorbic International in relation to the reverse acquisition exercise, a final amount of £137,202 was recognised in addition to £73,917 of expenses reimbursement, and £90,506 of advisory and consultancy service fees to Honour Field International.

 

- Ends -

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ZXLFLFQFLBBB

Related Shares:

Sorbic International
FTSE 100 Latest
Value8,275.66
Change0.00